GlaxoSmithKline has decided to slash the price of the widely-used fever and pain-relief pill, Crocin Advance by half, after the drug pricing regulator National Pharmaceuticals Pricing Authority (NPPA) rejected its application seeking an exemption from price control.
Put the internet to work for you.
No comments:
Post a Comment